Flex Seal Returns as Sponsor for Operation Christmas Drop, Donating Essential Repair Products
WESTON, Fla., Dec. 15, 2025 /PRNewswire/ — The Flex Seal Family of Products is proud to announce its support of Operation Christmas Drop, the Department of... Read more.
Stavtar Appoints Nick DeSalvo as Vice President of Sales
NEW YORK, Dec. 15, 2025 /PRNewswire/ — Stavtar Solutions, a leading provider of business spend management and expense allocation SaaS for complex enterprises... Read more.
GIBO Announces Strategic Collaboration with E Total Technology Sdn Bhd to Accelerate Deployment of AI Compute Centers Featuring NVIDIA’s Most Advanced Chips
KUALA LUMPUR, Malaysia, Dec. 15, 2025 /PRNewswire/ — GIBO Holdings Ltd. (NASDAQ: GIBO) today announced a strategic collaboration with Malaysia-based technology... Read more.
Gloo Unveils the First Benchmark Exposing How AI Misses Christian Worldview and Values
Research-backed framework shows models lack explicit biblical grounding, theological coherence and moral clarity around key dimensions of human flourishing BOULDER,... Read more.
OsteoCentric Technologies Appoints RJ Brideau to Board of Directors
AUSTIN, Texas, Dec. 15, 2025 /PRNewswire/ — OsteoCentric Technologies announced today the appointment of RJ Brideau to its Board of Directors, strengthening... Read more.
Opus Fund Services Tops Global Custodian’s Hedge Fund Administration Awards for Fourth Consecutive Year
Opus wins 2025 Administrator of the Year, Best Client Service and Best Technology awards NEW YORK and LONDON, Dec. 15, 2025 /PRNewswire/ — Opus Fund Services,... Read more.
Premier Equipment Company acquires Winston Tractor Company
ROCKY MOUNT, N.C., Dec. 15, 2025 /PRNewswire/ — Premier Equipment Company acquired Winston Tractor Company based in Winston-Salem, NC on December 15, 2025,... Read more.
All-new Hyundai NEXO Achieves Maximum Five-Star Rating in Euro NCAP Safety Assessment
Hyundai’s next-generation hydrogen fuel-cell electric SUV earns top scores across all major safety categories Achieves outstanding results in Adult and Child... Read more.
Kenai Therapeutics Announces First Patient Dosed in Phase 1 REPLACE™ Clinical Trial of Neuron Replacement Cell Therapy RNDP-001 for Idiopathic Parkinson’s Disease
Fast Track designation granted by U.S. FDA Initial safety, tolerability and brain imaging data from the trial are expected in 2026 SAN DIEGO, Dec. 15, 2025 /PRNewswire/... Read more.
Diakonos Oncology to Present Corporate Overview and Participate in Panel at 2026 Biotech Showcase
HOUSTON, Dec. 15, 2025 /PRNewswire/ — Diakonos Oncology Corp., a clinical-stage biotechnology company developing a new generation of immunotherapies to treat... Read more.